ClinicalTrials.gg
CompletedNCT05703100LacFatUpdated Sep 13, 2023

Lactate Profile and Fat Oxidation During Exercise

An interventional study of Incremental exercise test and Incremental exercise test under hyperthermia in Energy Metabolism, sponsored by Technical University of Madrid. Completed at 1 site in Spain. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-13.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Technical University of Madrid · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test whether changes in lactate kinetics during exercise (due to glycogen depletion or hyperthermia) alter the pattern of fat oxidation during a maximal incremental cycle ergometer test in healthy young active people. The main questions it aims to answer are:

  • Will a rightward shift in lactate kinetics, induced by a previous glycogen depletion, produce a rightward shift in fat oxidation?
  • Will a leftward shift in lactate kinetics due to an increase in ambient temperature produce a leftward shift in fat oxidation?

Participants will perform three maximal incremental tests in three different conditions:

  • one in the control condition;
  • one with glycogen depletion;
  • and one with ambient heat (the latter two in randomized, counterbalanced order).
Read the detailed description

Introduction Lactate has three major functions: it is an energy substrate, it is a gluconeogenic precursor, and it is a signalling molecule (1). Among the signalling functions is that of modulating skeletal muscle metabolism, as a regulator of fat oxidation at both the autocrine and paracrine levels. At the autocrine level, lactate increases the levels of Acetyl-coenzyme A (CoA) inside the mitochondria and, consequently, the levels of Malonyl-CoA. The increase in Malonyl-CoA concentration inhibits Carnitine PalmitoylTransferase 1 (CPT1), which is one of the transporters of fatty acids into the mitochondria (2). At the paracrine level, an increase in blood lactate concentration reduces the release of fatty acids into the blood by adipose tissue (3). This occurs because the G protein-coupled receptor present in adipose tissue inhibits the release of fatty acids into the blood when the blood lactate concentration increases (4). However, in vivo, only an inverse correlation between blood lactate concentration and fatty acid oxidation has been demonstrated (5,6). Therefore, the main objective of the study is to observe whether the pattern of fat oxidation during a maximal incremental cycle ergometer trial is altered due to changes in lactate kinetics during the given trial. For this purpose, three maximal trials will be performed with the same loading protocol (intensity and progression of the same), but different physiological conditions (normal vs. previous glycogen depletion vs. environmental hyperthermia).

Procedures Consent to participate (signature of informed consent) will be requested from all volunteers who meet the inclusion criteria.

The tests that will be performed throughout this study will be the following:

  1. At the first appointment, you will be asked about your medical history. Then, if appropriate, an assessment of your body composition by dual X-ray absorptiometry (DEXA) will be performed,
  2. In the second appointment, spirometry, an electrocardiogram at rest, and finally, an ergospirometric trial will be performed.
  3. In the third, fourth, and fifth visits, three maximal exercise trials will be performed, one each day. Of the three maximum ergospirometric trials that will be performed, one will be in a hot environment -approximately 38º Celsius (ºC) ambient temperature- and the other in a state of glycogen depletion. A glycogen depletion protocol and a low-carbohydrate diet will be performed before the maximal ergospirometric trial in the glycogen-depleted state, while the other two trials (simple maximal trial and hot-environment maximal trial) will be performed after 24h of a high-carbohydrate diet.
  4. The order of performance of each protocol will be randomized, provided that the glycogen depletion protocol is performed at the visit prior to the maximal ergospirometric trial under glycogen depletion. The depletion protocol consists of a 60-minute continuous cycle ergometer effort at the power associated with 60% of the maximal oxygen uptake (VO2) followed by six 30-second maximal efforts with four minutes of recovery. After this glycogen depletion exercise protocol, the participant will follow a low-carbohydrate diet (2% carbohydrate, 78% fat, and 20% protein), until the time of the ergospirometric trial under glycogen depletion status.
02

Conditions studied

  • Energy Metabolism

Browse trials for

Keywords

  • lactate kinetics
  • exercise
  • energy metabolism
  • hyperthermia
  • glycogen depletion
03

In context

Motor Activity Unverified

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

This study's enrollment of 19 is below the median of 60 across 8,412 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Technical University of Madrid is the lead sponsor of 14 studies on the registry; 3 are open to participants now.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Perform endurance training with a volume of between 3 and 12h/week
  • In women, having regular menstrual cycles (25-35 days length)
  • In women, being able to perform the test without menstrual discomfort or pain and without having taken anti-inflammatory or analgesic drugs

Exclusion criteria

Exclusion Criteria:

  • Suffering from any previous disease, disorder or ailment that could affect the results of the study variables
  • Smoking
  • In women, using any type of hormonal
  • In women, having heavy menstrual bleeding, detected with the menstrual bleeding questionnaire proposed by Wyatt et al. (2001)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • Active comparator
    Control

    Maximal test on a cycle ergometer

    Other: Incremental exercise test

  • Experimental
    Hyperthermia

    Maximal test on a cycle ergometer at 35º-38º C room temperature

    Other: Incremental exercise test under hyperthermia

  • Experimental
    Glycogen depletion

    Maximal test on a cycle ergometer after a glycogen depletion protocol

    Other: Incremental exercise test under glycogen depletion

Interventions

  • OtherIncremental exercise test

    Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W)

    Also known as: Maximal incremental ergometry

  • OtherIncremental exercise test under hyperthermia

    Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W) performed at a room temperature of 35-38ºC (degrees Celsius).

    Also known as: Maximal incremental ergometry with hyperthermia

  • OtherIncremental exercise test under glycogen depletion

    Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W) under glycogen depletion by performing an exercise protocol to deplete glycogen stores plus a low-carbohydrate diet 24 h before incremental testing

    Also known as: Maximal incremental ergometry with glycogen depletion

06

What researchers measure

Primary outcomes

  1. Blood lactate concentration

    Lactate concentration, expressed in mMol/L (Millimoles Per Liter), measured in capillary blood using a lactate analyser. Lactate concentration is measured in the capillary blood extracted from the fingertip, during the tests performed in the different situations (control, glycogen depletion and hyperthermia)

    Time frame: Through study completion, an average of 5 months

  2. Fat oxidation

    Fat oxidation, expressed in g/min, is indirectly measured through the analysis of the gas composition of breathing (O2 and CO2), using a gas analyser. Fat oxidation is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)

    Time frame: Through study completion, an average of 5 months

Secondary outcomes

  1. Heart Rate

    Heart rate, expressed in bpm (beats per minute), is measured using a pulsometer. Heart rate is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)

    Time frame: Through study completion, an average of 5 months

  2. Power output

    Power output, expressed in watts, is measured with a cycle ergometer. Power output is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)

    Time frame: Through study completion, an average of 5 months

07

Study locations

1 site
  • Laboratorio de Fisiología del Esfuerzo. Facultad de Ciencias de la Actividad Física y del Deporte (INEF)
    Madrid, 28040, Spain
08

References and documents

Publications

  • Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril. 2001 Jul;76(1):125-31. doi: 10.1016/s0015-0282(01)01847-7. PubMed 11438330 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2023 to primary completion in May 2023, 3 months.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 3 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 11, 2023
First posted
Jan 27, 2023
StartActual
Jan 28, 2023
Primary completionActual
May 11, 2023
CompletionActual
May 11, 2023
Last update
Sep 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05703100
Lead sponsor
Technical University of Madrid
Responsible party
Rocío Cupeiro, PhD (Physical Activity and Sports PhD (Associate Professor), Technical University of Madrid) — Principal investigator
First posted
Jan 27, 2023
Start date
Jan 28, 2023
Primary completion
May 11, 2023
Completion
May 11, 2023
Last update
Sep 13, 2023

Study contacts

Rocío Cupeiro, PhD
principal investigator · Universidad Politecnica de Madrid

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion